Altria Recognized for Environmental Leadership
Get Alerts MO Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 6.6%
Revenue Growth %: -12.6%
Join SI Premium – FREE
Science Based Targets initiative commends 1.5°C-aligned target, currently the highest designation available
RICHMOND, Va.--(BUSINESS WIRE)-- Altria Group, Inc. (“Altria”) (NYSE: MO) today announced that its greenhouse gas emissions reduction targets have been approved for the first time by the Science Based Targets initiative (SBTi). The Scope 1 and 2 target covering greenhouse gas emissions from Altria’s operations is consistent with reductions required to keep warming to 1.5°C, a goal that the latest climate science says is needed to prevent the most damaging effects of climate change. The Scope 3 target meets the criteria for ambitious value chain goals and current best practice.
“We believe it’s important to continually work to address important social and environmental challenges,” said Jennifer Hunter, Senior Vice President, Corporate Citizenship. “This is why we’ve set a higher bar and reset our long-term goals, including achieving 100% renewable electricity by 2030, 100% water neutrality annually, and aligning our business with the most ambitious greenhouse gas emissions reduction targets designated by the SBTi.”
In addition to SBTi approval, for the third year in a row Altria has been named to CDP’s Water A-List, among only 2% of disclosing global companies in 2019, and is recognized on CDP’s 2019 Climate Change survey as a global leader for engagement with suppliers on climate change.
Over 900 companies have committed to the SBTi, and just over 400 have SBTi-approved targets. SBTi is a collaboration between CDP, the United Nations Global Compact, World Resources Institute (WRI) and the World Wide Fund for Nature (WWF). The SBTi defines and promotes best practice in science-based target setting and independently assesses companies’ targets.
Altria’s recently released 2019 Corporate Responsibility Progress Report details the company’s continued progress on these environmental goals and on Altria’s four responsibility priorities: reducing the harm of tobacco products, including preventing underage tobacco use; marketing responsibly; managing our supply chain responsibly; and developing our employees and culture.
Altria’s Profile
Altria’s wholly owned subsidiaries include Philip Morris USA Inc. (PM USA), U.S. Smokeless Tobacco Company LLC (USSTC), John Middleton Co. (Middleton), Sherman Group Holdings, LLC and its subsidiaries (Nat Sherman), Ste. Michelle Wine Estates Ltd. (Ste. Michelle) and Philip Morris Capital Corporation (PMCC). Altria owns an 80% interest in Helix Innovations LLC (Helix). Altria holds equity investments in AnheuserBusch InBev SA/NV (ABI), JUUL Labs, Inc. (JUUL) and Cronos Group Inc. (Cronos).
The brand portfolios of Altria’s tobacco operating companies include Marlboro®, Black & Mild®, Copenhagen®, Skoal® and on!®. Ste. Michelle produces and markets premium wines sold under various labels, including Chateau Ste. Michelle®, 14 Hands® and Stag’s Leap Wine Cellars™, and it imports and markets Antinori®, Champagne Nicolas Feuillatte™ and Villa Maria Estate™ products in the United States. Trademarks and service marks related to Altria referenced in this release are the property of Altria or its subsidiaries or are used with permission.
More information about Altria is available at altria.com and on the Altria Investor app, or follow Altria on Twitter, Facebook and LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200709005860/en/
Altria Client Services
Media Affairs
(804) 484-8897 (804) 484-8897
Source: Altria Group, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Faraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: Announces Upcoming EAI Robotics Major Launch Events in June, Along with the First Cooperation Agreement with U.S. K-12 Publi
- Antengene Presented First Preclinical Data at EULAR 2026 Showing ATG-207 Promotes Regulatory T Cell Induction and Immune Tolerance
- Christina Taft Connects Monaco-Inspired Vision Rooted in Elegance and Purpose
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share